P-319 - Long term efficacy results from the phase II CRAB trial: Neoadjuvant bevacizumab, capecitabine and radiotherapy in locally advanced rectal cancer

Autor: Velenik, V., Omejc, M., Ocvirk, J., Edhemović, I., Anderluh, F., Oblak, I., But-Hadzic, J.
Zdroj: In Annals of Oncology June 2018 29 Supplement 5:v89-v90
Databáze: ScienceDirect